PHARMA ANALYTICS LTD

Company Registration Number:
11658356 (England and Wales)

Unaudited micro entity accounts for the year ended 30 November 2023

Period of accounts

Start date: 01 December 2022

End date: 30 November 2023

PHARMA ANALYTICS LTD

Contents of the Financial Statements

for the Period Ended 30 November 2023

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

PHARMA ANALYTICS LTD

Company Information

for the Period Ended 30 November 2023




Registered office: Flat 19, Balearic Apartments
15 Western Gateway
London
England
E16 1AP
Company Registration Number: 11658356 (England and Wales)

PHARMA ANALYTICS LTD

Balance sheet

As at 30 November 2023


2023
£

2022
£
Called up share capital not paid: 0 0
Current assets: 8,478 57,138
Net current assets (liabilities): 8,478 57,138
Total assets less current liabilities: 8,478 57,138
Total net assets (liabilities): 8,478 57,138
Capital and reserves: 8,478 57,138

PHARMA ANALYTICS LTD

Balance sheet continued

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 20 August 2024
And Signed On Behalf Of The Board By:

Name: Gordon Murphy
Status: Director

The notes form part of these financial statements

PHARMA ANALYTICS LTD

Footnotes to the Financial Statements

for the Period Ended 30 November 2023

  • 1. Employee Information

    Average number of employees: 1

PHARMA ANALYTICS LTD

Footnotes to the Financial Statements

for the Period Ended 30 November 2023

  • 2. Off balance sheet disclosure

    No